|
Personal data - diagnosis
|
Personal data
| Visible name: |
Peter54 |
| Ctry: |
Deutschland |
| State/Province: |
|
| Year of birth: |
1954 |
| Age: |
71 |
| Occupation: |
|
| Hobbies: |
|
| My Website: |
|
|
Data at initial diagnosis
| Date: |
18.04.2012 |
| Age at diagnosis: |
58 |
| PSA: |
41.30 |
| Biopsied? |
Yes |
| TUR-P? |
No |
| Gleason Score: |
4 + 3 = 7b |
| TNM-Stages: |
cT2c cN0 cM0 |
| Remark: |
|
|
|
Maximum measured prostate volume
| Date: |
18.04.2012 |
| PSA: |
41.30 |
| Volume in ml or cm³: |
26 |
|
Postoperative pathological data
| Date: |
|
| Gleason Score: |
|
| pTNM-classification: |
|
| Margins: |
|
| p-L-V-P-G-Findings: |
|
| See stories of: |
|
|
|
Prostate cancer treatments
** PSA level at the start of the treatment
|
| from |
to |
PSA** |
Type |
Clinic |
City |
|
08.10.12 |
03.12.12 |
33.00 |
IMRT + ADT |
Uniklinik |
Tübingen |
|
|
Drugs
NEM = Nutritional supplement
|
| from |
to |
Medication |
Quantity / unit of time |
|
15.07.12 |
24.07.12 |
Bicalutin/Bicalutamid |
150mg/T |
|
25.07.12 |
|
Trenantone |
3-Monatsspritze |
|
02.08.12 |
|
Dekristol 20.000 i.E. (Vitamin D3) |
1 mg/W |
|
02.08.12 |
|
Granaprostan (NEM) |
600 mg/d |
|
02.08.12 |
|
Salvestrol 2000 (NEM) |
320 mg/d |
|
02.08.12 |
|
orthomol immun (NEM) |
|
|
02.08.12 |
|
orthomol i-care (NEM) |
|
|
02.08.12 |
01.02.13 |
Cefasel (Selen) |
150 mg/2d |
|
02.08.12 |
01.02.13 |
Q 10 (NEM) |
60 mg/d |
|
16.10.12 |
|
Trenantone |
3-Monatsspritze |
|
16.10.12 |
|
Cialis |
5 mg/d |
|
14.01.13 |
|
Trenantone |
3-Monatsspritze |
|
01.02.13 |
|
Q10 (NEM) |
90 mg/d |
|
01.02.13 |
|
Cefasel(Selen) |
150 mg 2x/W |
|
09.04.13 |
|
Trenantone |
3-Monatsspritze |
|
05.07.13 |
|
Trenantone |
3-Monatsspritze |
|
11.10.13 |
|
Trenantone |
3-Monatsspritze |
|
10.01.14 |
|
Trenantone |
3-Monatsspritze |
|
08.04.14 |
|
Trenantone |
3-Monatsspritze |
|
06.07.14 |
|
Trenantone |
3-Monatsspritze |
|
14.10.14 |
|
Trenantone |
3-Monatsspritze |
|
06.01.15 |
|
Trenantone |
3-Monatsspritze |
|
09.04.15 |
|
Trenantone |
3-Monatsspritze |
Quantity per D / M / Y etc.
|
